L. Ozelius, G. Senthil, and R. Saunders-pullman, G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews, New England Journal of Medicine, vol.354, issue.4, pp.424-425, 2006.
DOI : 10.1056/NEJMc055509

S. Goldwurm, M. Zini, and L. Mariani, Evaluation of LRRK2 G2019S penetrance: Relevance for genetic counseling in Parkinson disease, Neurology, vol.68, issue.14, pp.1141-1143, 2007.
DOI : 10.1212/01.wnl.0000254483.19854.ef

M. Hulihan, L. Ishihara-paul, and J. Kachergus, LRRK2 Gly2019Ser penetrance in Arab???Berber patients from Tunisia: a case-control genetic study, The Lancet Neurology, vol.7, issue.7, pp.591-594, 2008.
DOI : 10.1016/S1474-4422(08)70116-9

S. Lesage, A. Durr, and M. Tazir, G2019S as a Cause of Parkinson's Disease in North African Arabs, New England Journal of Medicine, vol.354, issue.4, pp.422-423, 2006.
DOI : 10.1056/NEJMc055540

URL : https://hal.archives-ouvertes.fr/hal-00221453

S. Lesage, E. Patin, and C. Condroyer, Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans, Human Molecular Genetics, vol.19, issue.10, pp.1998-2004, 2010.
DOI : 10.1093/hmg/ddq081

URL : https://hal.archives-ouvertes.fr/inserm-00522011

W. Rocca, S. Mcdonnell, and K. Strain, Familial aggregation of Parkinson's disease: The Mayo Clinic family study, Annals of Neurology, vol.13, issue.4, pp.495-502, 2004.
DOI : 10.1002/ana.20228

A. Elbaz, LRRK2: bridging the gap between sporadic and hereditary Parkinson's disease, The Lancet Neurology, vol.7, issue.7, pp.562-564, 2008.
DOI : 10.1016/S1474-4422(08)70118-2